Cite
Investigation of Terminalia arjuna as potential IL-4 and IL-13 modulator for the prevention of autoimmune diabetes: A Pharmacoinformatics-based study.
MLA
Unnisa, Aziz, et al. “Investigation of Terminalia Arjuna as Potential IL-4 and IL-13 Modulator for the Prevention of Autoimmune Diabetes: A Pharmacoinformatics-Based Study.” Kuwait Journal of Science, vol. 50, no. 1A, Jan. 2023, pp. 1–14. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=161493754&authtype=sso&custid=ns315887.
APA
Unnisa, A., Ahmad, S., Jandrajupalli, S. B., Younes1., K. M., Abobaker, S. H., Chandolu, S., Khalid, M., & N., L. S. (2023). Investigation of Terminalia arjuna as potential IL-4 and IL-13 modulator for the prevention of autoimmune diabetes: A Pharmacoinformatics-based study. Kuwait Journal of Science, 50(1A), 1–14.
Chicago
Unnisa, Aziz, Saheem Ahmad, Suresh Babu Jandrajupalli, Kareem M. Younes1., Sally Hassan Abobaker, Swarnalatha Chandolu, Mohammad Khalid, and Lakshmi Sudeepthi N. 2023. “Investigation of Terminalia Arjuna as Potential IL-4 and IL-13 Modulator for the Prevention of Autoimmune Diabetes: A Pharmacoinformatics-Based Study.” Kuwait Journal of Science 50 (1A): 1–14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=161493754&authtype=sso&custid=ns315887.